| 产品名 | |||
| Pimasertib (AS-703026) | MEK | 卵巢癌,黑色素瘤 | Phase 2 |
| MLN2480 | Raf | 黑色素瘤 | Phase 1 |
| RG7304 | MEK | 实体瘤,骨髓瘤 | Phase 1 |
| GDC-0994 | ERK | 实体瘤 | Phase 1 |
| Peficitinib (ASP015K, JNJ-54781532) | JAK | 类风湿性关节炎 | Phase 3 |
| LY2784544 | JAK | 骨髓增生性疾病 | Phase 2 |
| Filgotinib (GLPG0634) | JAK | 类风湿性关节炎,克罗恩病 | Phase 2 |
| Losmapimod (GW856553X) | p38 MAPK | 急性冠脉综合征 | Phase 3 |
| SB-681323 | p38 MAPK | 类风湿性关节炎,神经性疼痛,冠状动脉疾病,阻塞性肺疾病 | Phase 2 |
| PH-797804 | p38 MAPK | 阻塞性肺疾病,带状疱疹后神经痛,类风湿性关节炎 | Phase 2 |
| Tak-715 | p38 MAPK | 类风湿性关节炎 | Phase 2 |
| BMS-582949 | p38 MAPK | 类风湿性关节炎 | Phase 2 |
| Fostamatinib (R788) | Syk | 血小板减少性紫癜 | Phase 3 |
| Entospletinib (GS-9973) | Syk | 淋巴瘤,白血病 | Phase 2 |
| PRT062607 (P505-15, BIIB057) HCl | Syk | 类风湿关节炎,狼疮 | Phase 2 |
| Trelagliptin (SYR-472) | DPP-4 | 糖尿病 | Phase 3 |
| Omarigliptin (MK-3102) | DPP-4 | 糖尿病 | Phase 3 |
| Asunaprevir (BMS-650032) | HCV Protease | HCV感染 | Phase 3 |
| Faldaprevir (BI 201335) | HCV Protease | HCV感染 | Phase 3 |
| Vaniprevir (MK-7009) | HCV Protease | HCV感染 | Phase 3 |
| Danoprevir (ITMN-191) | HCV Protease | HCV感染 | Phase 2 |
| GS-9451 | HCV Protease | HCV感染 | Phase 2 |
| GS-9669 | HCV Protease | HCV感染 | Phase 2 |
